Delaware Court Unseals Qui Tam Case Alleging False Claims About Unused Gift Cards
In a recently-unsealed whistleblower lawsuit initiated under the laws of Delaware, dozens of companies organized under Delaware law are facing possible exposure to liability for failing to escheat the value of unclaimed gift cards to the State. Escheat is a term referring to the legal requirement imposed by Delaware’s unclaimed […]
St. Jude’s Medical, Inc. Under Investigation by DOJ for Possible False Claims Act Violations
Costly fraud against the U.S. government can occur in virtually any sector; however, it is being discovered within the medical and healthcare sector with increasing consistency. In a recent filing with the Securities and Exchange Commission, St. Jude’s Medical, Inc., a global medical device manufacturer, has revealed it is under […]
Jacksonville Hospital Baptist Health Settles False Claims Act Lawsuit for $2.5 Million
Jacksonville-area hospital Baptist Health, through its parent company, has agreed to pay $2.5 million to settle a whistleblower lawsuit alleging healthcare fraud. The hospital is accused of having unlawfully exploited Medicare and Medicaid funds by billing the government for services not rendered or for services rendered that were not medically […]
Long Island Radiologist to Pay Over $15 Million to Settle False Claims Act Allegations
Fraud in the healthcare industry is reaching alarming levels. Each year, the Department of Justice works in concert with several other federal agencies and state-level counterparts to combat this growing trend. The False Claims Act is extremely pivotal in bringing healthcare fraud to light. Given the widespread problem of fraud […]
U.S. Solicitor General Explains the Inapplicability of Rule 9(b) in the False Claims Act
As we reported yesterday, the U.S. Solicitor General, upon request by the Supreme Court, submitted its amicus curiae brief in the hotly-contested False Claims Act case Nathan v. Takeda Pharmaceuticals. As a bit of background, this case involves the practice of off-label marketing, which occurs when a drug company promotes […]